Who
Peter M. Neupert
Director
Company insider
Files Form 4 as: Director, Adaptive Biotechnologies; Chief Executive Officer, Fortrea Holdings; Director, Labcorp Holdings; Director, Quality Systems; Director, Aquantive.
In numbers
- Trades disclosed
- 95
- Buys
- 4
- Sells
- 2
- Bought
- $1.6M
- Sold
- $6.3M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 10 May 2006
- Last trade
- 17 Aug 2026
- Last filed
- 19 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $95K15,000 at $6.32 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $378K15,000 at $25.23 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $1.0M40,000 at $25.10 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $1.8M69,690 at $25.16 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $95K15,000 at $6.32 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $378K15,000 at $25.23 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $1.0M40,000 at $25.10 | filing |
| 17 Aug 2026filed 19 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $1.8M69,690 at $25.16 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —12,852 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —12,852 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —148,536 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —148,536 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —148,536 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —148,536 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —15,625 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —15,625 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —897 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —897 at $0.00 | filing |
News
Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells 11,881 Shares of Company StockADPT · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name Peter M. Neupert; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.